Recruiting Bipolar Disorder Studies in Riverside
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, inpatient study in participants with bipolar disorder experiencing an acute episode of mania or mania with mixed features....
ALTO-100 in Bipolar Disorder With Depression (BD-D)
The purpose of this study is to assess antidepressant efficacy differences between ALTO-100 and placebo during the Double-Blind period in patients with bipolar disorder I or II with current major depr...
About Bipolar Disorder Clinical Trials in Riverside
Bipolar disorder is a mental health condition marked by extreme mood swings including emotional highs (mania or hypomania) and lows (depression). It affects about 2.8% of adults in the U.S. Treatment typically involves mood stabilizers, antipsychotics, and psychotherapy.
There are currently 2 bipolar disorder clinical trials recruiting participants in Riverside, CA. These studies are seeking a combined 474 participants. Research is being sponsored by Bristol-Myers Squibb, Alto Neuroscience. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bipolar Disorder Clinical Trials in Riverside — FAQ
Are there bipolar disorder clinical trials in Riverside?
Yes, there are 2 bipolar disorder clinical trials currently recruiting in Riverside, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Riverside?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Riverside research site will contact you about next steps.
Are clinical trials in Riverside free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Riverside studies also compensate for your time and travel.
What bipolar disorder treatments are being tested?
The 2 active trials in Riverside are testing new therapies including novel drugs, biologics, and treatment approaches for bipolar disorder.
Data updated March 2, 2026 from ClinicalTrials.gov